ChartRow logo
Sign in
ALNY
Alnylam Pharmaceuticals Inc.Stock · Health Care · Nasdaq-100 0.2%
$227.00+$3.05 (+1.36%)as of market close, Aug 13, 2026
☾ After hours:$227.12+0.00%3:59 PM ET
CompareLLYUNHJNJABBVISRGTMO

How Alnylam Pharmaceuticals uses its cash

Period

Where does Alnylam Pharmaceuticals's cash go? This Sankey traces cash from net income through operating cash flow into capex, free cash flow, dividends, buybacks, and debt paydown. Pick any fiscal year, recent quarter, or the trailing twelve months. Straight from SEC filings.

Alnylam Pharmaceuticals Inc. · FY2025 · year ended 2025-12-31
Operating cash flow$524MCash from operations$718M · 137%Net income$314M · 60%D&A$56M · 11%Stock comp$348M · 66%Working capital$194M · 37%Capex$59M · 11%Free cash flow$465M · 89%Cash retained$465M · 89%

Each fiscal year from SEC filings. Percentages are share of operating cash flow. Sources (net income + non-cash add-backs) flow into operating cash flow, which splits into capex and free cash flow; free cash flow goes to dividends, buybacks, debt paydown, and what's retained. Annual only. For informational purposes only.